Literature DB >> 16918732

Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure.

Kevin P Weinfurt1, Joëlle Y Friedman, Jennifer S Allsbrook, Michaela A Dinan, Mark A Hall, Jeremy Sugarman.   

Abstract

BACKGROUND: There is little guidance regarding how to disclose researchers' financial interests to potential research participants.
OBJECTIVE: To determine what potential research participants want to know about financial interests, their capacity to understand disclosed information and its implications, and the reactions of potential research participants to a proposed disclosure statement. DESIGN AND PARTICIPANTS: Sixteen focus groups in 3 cities, including 6 groups of healthy adults, 6 groups of adults with mild chronic illness, 1 group of parents of healthy children, 1 group of parents of children with leukemia or brain tumor, 1 group of adults with heart failure, and 1 group of adults with cancer. APPROACH: Focus group discussions covered a range of topics including financial relationships in clinical research, whether people should be told about them, and how they should be told. Audio-recordings of focus groups were transcribed, verified, and coded for analysis.
RESULTS: Participants wanted to know about financial interests, whether or not those interests would affect their participation. However, they varied in their desire and ability to understand the nature and implications of financial interests. Whether disclosure was deemed important depended upon the risk of the research. Trust in clinicians was also related to views regarding disclosure. If given the opportunity to ask questions during the consent process, some participants would not have known what to ask; however, after the focus group sessions, participants could identify information they would want to know.
CONCLUSIONS: Financial interests are important to potential research participants, but obstacles to effective disclosure exist.

Entities:  

Mesh:

Year:  2006        PMID: 16918732      PMCID: PMC1831594          DOI: 10.1111/j.1525-1497.2006.00502.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  7 in total

1.  Disclosure of physician incentives: do practices satisfy purposes?

Authors:  M A Hall; K E Kidd; E Dugan
Journal:  Health Aff (Millwood)       Date:  2000 Jul-Aug       Impact factor: 6.301

2.  Protecting subjects, preserving trust, promoting progress II: principles and recommendations for oversight of an institution's financial interests in human subjects research.

Authors: 
Journal:  Acad Med       Date:  2003-02       Impact factor: 6.893

3.  Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research.

Authors: 
Journal:  Acad Med       Date:  2003-02       Impact factor: 6.893

4.  American Society of Clinical Oncology: revised conflict of interest policy.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-29       Impact factor: 44.544

5.  (Almost) everything you ever wanted to know about informed consent. [Review of: Faden, RR and Beauchamp, TL. A history and theory of informed concsent. New York and Oxford: Oxford University Press, 1986].

Authors:  A M Capron
Journal:  Med Humanit Rev       Date:  1987-01

Review 6.  Informing consumer decisions in health care: implications from decision-making research.

Authors:  J H Hibbard; P Slovic; J J Jewett
Journal:  Milbank Q       Date:  1997       Impact factor: 4.911

7.  Potential research participants' views regarding researcher and institutional financial conflicts of interest.

Authors:  S Y H Kim; R W Millard; P Nisbet; C Cox; E D Caine
Journal:  J Med Ethics       Date:  2004-02       Impact factor: 2.903

  7 in total
  19 in total

Review 1.  Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics.

Authors:  Lilyana Amezcua; Flavia Nelson
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey.

Authors:  Genevieve Pham-Kanter; Michelle M Mello; Lisa Soleymani Lehmann; Eric G Campbell; Daniel Carpenter
Journal:  J Gen Intern Med       Date:  2017-03-06       Impact factor: 5.128

3.  Why disclosure?

Authors:  Raymond De Vries; Carl Elliott
Journal:  J Gen Intern Med       Date:  2006-09       Impact factor: 5.128

4.  Developing model language for disclosing financial interests to potential clinical research participants.

Authors:  Kevin P Weinfurt; Jennifer S Allsbrook; Joëlle Y Friedman; Michaela A Dinan; Mark A Hall; Kevin A Schulman; Jeremy Sugarman
Journal:  IRB       Date:  2007 Jan-Feb

5.  Here Comes the Sunshine: Industry's Payments to Cardiothoracic Surgeons.

Authors:  Rizwan Ahmed; Sunjae Bae; Caitlin W Hicks; Babak J Orandi; Chady Atallah; Eric K Chow; Allan B Massie; Joseph Lopez; Robert S Higgins; Dorry L Segev
Journal:  Ann Thorac Surg       Date:  2016-06-25       Impact factor: 4.330

6.  Comparison of conflict of interest policies and reported practices in academic medical centers in the United States.

Authors:  Michaela A Dinan; Kevin P Weinfurt; Joëlle Y Friedman; Jennifer S Allsbrook; Julie Gottlieb; Kevin A Schulman; Mark A Hall; Jatinder K Dhillon; Jeremy Sugarman
Journal:  Account Res       Date:  2006 Oct-Dec       Impact factor: 2.622

7.  The cycle of bias in health research: a framework and toolbox for critical appraisal training.

Authors:  Donna H Odierna; Susan R Forsyth; Jenny White; Lisa A Bero
Journal:  Account Res       Date:  2013       Impact factor: 2.622

8.  Key personnel and "long distance" settings: determining who must report financial conflict of interest.

Authors:  John Lynch; Christopher J Lindsell
Journal:  Account Res       Date:  2010-07       Impact factor: 2.622

9.  Effects of disclosing financial interests on attitudes toward clinical research.

Authors:  Kevin P Weinfurt; Mark A Hall; Michaela A Dinan; Venita DePuy; Joëlle Y Friedman; Jennifer S Allsbrook; Jeremy Sugarman
Journal:  J Gen Intern Med       Date:  2008-04-02       Impact factor: 5.128

10.  Planning for translational research in genomics.

Authors:  Naomi Hawkins; Jantina de Vries; Paula Boddington; Jane Kaye; Catherine Heeney
Journal:  Genome Med       Date:  2009-09-29       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.